| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66e092fce2c2d3f9a9efc3a708028a5c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-12022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-12034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b626ad031ad26f9b265254bbc21a8480
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_074ef6814d59ded1d41a5b09a20cb97b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1420dd0c1e252eae3b9a7ef5e3aea2e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_096a84d42e2d1fccf326195ed85d4819 |
| publicationDate |
2008-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2684555-A1 |
| titleOfInvention |
Use of hemagglutinin of the african swine fever virus as an adjuvant |
| abstract |
The invention generally concerns the use of of the haemoglutinin (HA) of the African swine pest virus (VPPA) as an adjuvant to promote the immune response to an antigen in a subject. The invention provides a genetic construction comprising all or part of the coding sequence of said HA fused with the coding sequence of an antigen. It has uses in human and animal health. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9644006-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014065175-A1 |
| priorityDate |
2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |